Havron Abraham
Pharmaceuticals
Kamada
Israel
Biography
Dr. Abraham Havron has served on our board of directors since March 2011 and is an external director within the meaning of the Companies Law. Since 2005 and until its acquisition by OPKO Health Inc. in 2013, Dr. Havron served as the Chief Executive Officer and a director of PROLOR Biotech Inc. Dr. Havron is a 34-year veteran of the biotechnology industry and was a member of the founding team and Director of Research and Development of Interpharm Laboratories Ltd. (a subsidiary of Merck Serono S.A.) from 1980 to 1987. Dr. Havron served as Vice-President Manufacturing and Process-Development of BioTechnology General Ltd., based in Rehovot, Israel (now, a subsidiary of Ferring Pharmaceuticals) from 1987 to 1999; and Vice President and Chief Technology Officer of Clal Biotechnology Industries Ltd. from 1999 to 2003. Dr. Havron earned his PhD in Bio-Organic Chemistry from the Weizmann Institute of Science, and served as a Research Fellow at the Harvard Medical School, Department of Radiology.
Research Interest
Bio-Organic Chemistry
